News
Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...
The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...
Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...
Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...
The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.
Goods shipped from the country face a 39 percent tariff in the U.S., which companies warn will have dire consequences if ...
President Trump sees Switzerland as doing too little to address its trade deficit with the U.S., a gap he focused on as he ...
Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...
The Alpine country of 9 million found out the hard way that the US is not here to help.
Switzerland’s economy unexpectedly grew in the second quarter, maintaining some momentum before the country was hit with one of the highest US tariff rates.The expansion of 0.1% was better than the ...
Switzerland’s exporters, from watch makers to pharmaceutical companies, are bracing for the financial fallout from US President Donald Trump’s 39% tariffs, one of the steepest rates globally in his ...
The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results